Angiogenesis is involved in the pathogenesis and progression of non-Hodgkin lymphomas (NHL), and hypoxia-inducible factor-1α (HIF-1α, also termed HIF1A) might contribute to this process. Currently, there is no direct evidence that the clinical progression of indolent NHL is associated with angiogenesis, and the expression of HIF-1α at recurrence is unknown. Matched lymph node biopsies at diagnosis and recurrence of relapsed/refractory indolent NHL patients were analysed by immunohistochemical and morphometric analysis. We observed an increased vascular network and HIF-1α protein expression in the second biopsy, providing direct evidence that angiogenesis is an essential process for disease progression. © 2013 John Wiley & Sons Ltd.
CITATION STYLE
Minoia, C., Quero, C., Asselti, M., Galise, I., Marzano, A. L., Iacobazzi, A., … Guarini, A. (2013). Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas. British Journal of Haematology, 163(5), 640–645. https://doi.org/10.1111/bjh.12560
Mendeley helps you to discover research relevant for your work.